DE602008004556D1 - Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin - Google Patents

Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin

Info

Publication number
DE602008004556D1
DE602008004556D1 DE602008004556T DE602008004556T DE602008004556D1 DE 602008004556 D1 DE602008004556 D1 DE 602008004556D1 DE 602008004556 T DE602008004556 T DE 602008004556T DE 602008004556 T DE602008004556 T DE 602008004556T DE 602008004556 D1 DE602008004556 D1 DE 602008004556D1
Authority
DE
Germany
Prior art keywords
compositions
histamine
methods
disorders associated
detecting disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602008004556T
Other languages
English (en)
Inventor
Denis Vincent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre Hospitalier Universitaire de Nimes
Original Assignee
Centre Hospitalier Universitaire de Nimes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Hospitalier Universitaire de Nimes filed Critical Centre Hospitalier Universitaire de Nimes
Publication of DE602008004556D1 publication Critical patent/DE602008004556D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/906—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE602008004556T 2007-07-31 2008-07-31 Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin Active DE602008004556D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07301286A EP2020446A1 (de) 2007-07-31 2007-07-31 Zusammensetzungen und Verfahren für den Nachweis von histaminbedingten Erkrankungen
PCT/EP2008/060057 WO2009016231A2 (en) 2007-07-31 2008-07-31 Compositions and methods for detecting histamine related disorders

Publications (1)

Publication Number Publication Date
DE602008004556D1 true DE602008004556D1 (de) 2011-02-24

Family

ID=38859059

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602008004556T Active DE602008004556D1 (de) 2007-07-31 2008-07-31 Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin

Country Status (6)

Country Link
US (1) US20100297631A1 (de)
EP (2) EP2020446A1 (de)
AT (1) ATE495271T1 (de)
CA (1) CA2695662A1 (de)
DE (1) DE602008004556D1 (de)
WO (1) WO2009016231A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2426539B1 (es) * 2012-04-18 2014-09-09 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)
WO2021160696A1 (en) * 2020-02-10 2021-08-19 Immundiagnostik Ag In-vitro diagnosis of histamine intolerance syndrome
EP4134672A1 (de) * 2021-08-09 2023-02-15 Immundiagnostik AG Differentialdiagnose bei einem histaminintoleranzsyndroms
WO2023017050A1 (en) * 2021-08-10 2023-02-16 Immundiagnostik Ag Differential diagnosis of histamine intolerance syndrome

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990010061A1 (en) * 1989-03-02 1990-09-07 Griffith University Diamine oxidase and assay for rupture of amniotic membrane in pregnant mammals
WO1997022002A1 (de) * 1995-12-08 1997-06-19 Reimann Hans Juergen Verfahren und vorrichtung zur in-vitro diagnose allergischer erkrankungen
US20050042630A1 (en) * 1999-01-06 2005-02-24 Chondrogene Limited Method for the detection of asthma related gene transcripts in blood
JP2004121218A (ja) * 2002-08-06 2004-04-22 Jenokkusu Soyaku Kenkyusho:Kk 気管支喘息または慢性閉塞性肺疾患の検査方法
AT411688B (de) * 2002-10-31 2004-04-26 Jarisch Reinhard Dr Verfahren zur bestimmung der aktivität von diaminooxidase
US7772011B2 (en) * 2005-03-21 2010-08-10 Ronald Joseph Harbeck Method and kit for detection of autoimmune chronic urticaria
AT502850B1 (de) * 2005-11-18 2007-08-15 Albert Dr Missbichler Verfahren zur bestimmung der aktivität von diaminooxidase

Also Published As

Publication number Publication date
CA2695662A1 (en) 2009-02-05
WO2009016231A3 (en) 2009-04-09
ATE495271T1 (de) 2011-01-15
WO2009016231A2 (en) 2009-02-05
US20100297631A1 (en) 2010-11-25
EP2020446A1 (de) 2009-02-04
EP2183389B1 (de) 2011-01-12
EP2183389A2 (de) 2010-05-12

Similar Documents

Publication Publication Date Title
HK1117083A1 (en) Compositions and methods for treatment of eye disorders
GB0421639D0 (en) Methods and compositions relating to alzheimer's disease
EA201590833A1 (ru) Антитела для лечения и профилактики болезни альцгеймера и их применение
MY164376A (en) Phosphospecific antibodies recognizing tau
ATE470151T1 (de) Diagnose, behandlung und prävention von gefässerkrankungen mittels il-1alpha- autoantikörpern
EA201290964A1 (ru) Пептидные конъюгаты агонистов рецептора glp-1 и их применение
CR20150016A (es) Anticuerpo monoclonal
WO2008042231A3 (en) Compositions and methods for evaluating and treating heart failure
WO2010057112A3 (en) Genetic variants underlying human cognition and methods of use thereof as diagnostic and therapeutic targets
EA200901550A1 (ru) Способы лечения, диагностирования и выявления ассоциированных с fgf21 нарушений
ATE432072T1 (de) Verwendung von adapalen zur behandlung dermatologischer erkrankungen
UY31114A1 (es) Anticuerpos humanizados contra el globulómero ab(20-42) y sus usos
EA200602062A1 (ru) Амидосоединения и их применение в качестве фармацевтических средств
MX2009004705A (es) Moleculas de enlace de albumina y usos de las mismas.
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
WO2009038689A3 (en) Compositions and methods for diagnosis and treatment of type 2 diabetes
BR112014007675A2 (pt) tratamento de doença articular degenerativa
ATE485517T1 (de) Verfahren zur identifizierung von polypeptid- targets
WO2007059064A3 (en) Fgf2-related methods for diagnosing and treating depression
WO2007000320A3 (de) Verfahren zur diagnose von rheumatischen erkrankungen
EA200901067A1 (ru) Использование семафорина 6а в качестве промотора миелинизации и дифференцировки олигодендроцитов
MY150098A (en) Benzylpiperazine derivates and their medical use
WO2006074450A3 (en) Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
DE602008004556D1 (de) Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin
DE602006002612D1 (de) Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on